BPMC
Blueprint Medicines
BPMC
BPMC
Delisted
BPMC was delisted on the 17th of July, 2025.
220 hedge funds and large institutions have $4.68B invested in Blueprint Medicines in 2019 Q2 according to their latest regulatory filings, with 54 funds opening new positions, 94 increasing their positions, 46 reducing their positions, and 34 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
8% more funds holding
Funds holding: 203 → 220 (+17)
8.55% less ownership
Funds ownership: 110.07% → 101.52% (-8.5%)
27% less funds holding in top 10
Funds holding in top 10: 11 → 8 (-3)
Holders
220
Holding in Top 10
8
Calls
$63.8M
Puts
$40.2M
Top Buyers
| 1 | +$169M | |
| 2 | +$67M | |
| 3 | +$36.1M | |
| 4 |
CCM
Cadian Capital Management
New York
|
+$30.5M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$30.4M |
Top Sellers
| 1 | -$77.2M | |
| 2 | -$70.4M | |
| 3 | -$21.1M | |
| 4 |
LCM
Laurion Capital Management
New York
|
-$21M |
| 5 |
CH
CVI Holdings
Wilmington,
Delaware
|
-$16M |